Case report shows quadruple regimen for cystic fibrosis infection

This report describes a 21-year-old man in China with cystic fibrosis who had a Mycobacterium abscessus infection and a Staphylococcus aureus infection. He received a quadruple antimycobacterial regimen of linezolid, moxifloxacin, azithromycin, and minocycline, combined with systemic supportive care. The report states that he achieved clinical stability. No safety events were reported, and no comparator was used. The study is a single case and literature review, so its findings are very limited and not generalizable. The main reason to be careful is that this is one person, and the report does not detail follow-up or long-term outcomes. Readers should see this as an example of personalized antimicrobial strategy in a complex infection, not as a proven treatment. It highlights the importance of early recognition of cystic fibrosis and improved access to essential medications, but it does not change standard care.